Table 2. Genotypic characteristics of representative Vibrio vulnificus strains as assessed by BOX-PCR genomic fingerprinting.
BOX-PCR profile no. a | Representative strain b | No. of strains c | Soruce of isolation d | 16S rRNA type e | CPS type e | vcg type e | pilF e | viuB e | vuuA e |
---|---|---|---|---|---|---|---|---|---|
1 | SC9629 | 2 | E | A | NA f | E | - | - | - |
2 | NV22 | 2 | E | A | NA | C | - | - | - |
3 | SC9729 | 1 | E | A | 2 | E | - | - | - |
4 | SC9740 | 1 | E | A | NA | E | - | - | - |
5 | SC9613 | 1 | E | A | NA | E | + g | - | - |
6 | CNUH94-4 | 1 | C | B | 1 | C | + | - | + |
7 | V-16 | 1 | C | B | 2 | C | + | - | + |
8 | CN8 | 2 | C | B | 1 | C | + | + | + |
9 | CN7 | 1 | C | B | 1 | C | + | + | + |
10 | YJ016 | 2 | C | B | 2 | C | + | + | + |
11 | SC9733 | 1 | E | B | 1 | C | + | - | + |
12 | CG122 | 1 | E | B | NA | C | + | + | - |
13 | CG55 | 2 | E | B | 2 | C | + | + | + |
14 | CG108 | 1 | E | B | 1 | C | + | + | + |
15 | SC9648 | 1 | E | B | 2 | C | + | - | + |
16 | SC9720 | 1 | E | B | 2 | C | + | - | + |
17 | SC9761 | 1 | E | A | 2 | E | + | - | + |
18 | NV63 | 2 | E | B | 2 | C | + | + | + |
19 | SC9737 | 1 | E | B | 1 | C | + | + | + |
20 | NV72 | 2 | E | B | 2 | C | + | + | + |
21 | CG27 | 4 | E | B | 1 | C | + | - | + |
22 | CG26 | 2 | E | B | 1 | C | + | + | + |
23 | SC97118 | 4 | E | B | 2 | C | + | + | + |
24 | WK22 | 2 | C | B | 1 | C | + | + | + |
25 | NV101 | 1 | E | B | NA | C | - | - | - |
26 | WK20 | 4 | C | B | 1 | C | + | + | + |
27 | V-19 | 1 | C | B | 1 | C | + | + | + |
28 | SC9717 | 1 | E | B | 1 | C | + | + | - |
29 | CG33 | 1 | E | B | 1 | C | + | - | + |
30 | CG62 | 2 | E | B | 2 | C | + | + | + |
31 | NV42 | 1 | E | B | 1 | C | + | + | + |
32 | CG21 | 1 | E | B | 1 | C | + | + | + |
33 | SC9794 | 1 | E | B | 1 | C | + | - | + |
34 | NV37 | 3 | E | B | 1 | C | - | + | - |
35 | SC9730 | 1 | E | B | 2 | C | + | + | - |
36 | SC9649 | 2 | E | B | 2 | C | + | + | + |
37 | CNUH94-3 | 1 | C | B | 1 | C | + | - | + |
38 | SC9721 | 1 | E | B | 2 | C | + | + | - |
39 | NV43 | 1 | E | B | 1 | C | + | + | - |
40 | NV28 | 3 | E | B | NA | C | + | + | - |
41 | NV31 | 2 | E | B | NA | C | + | - | - |
42 | NV18 | 1 | E | B | NA | C | + | + | - |
43 | SC9766 | 3 | E | B | NA | C | + | - | - |
44 | WK15 | 2 | C | B | 1 | C | + | + | + |
45 | WK6 | 1 | C | B | 1 | C | + | + | + |
46 | CG64 | 1 | E | B | 1 | C | + | + | + |
47 | NV1 | 3 | E | B | 1 | C | + | + | + |
48 | SC9793 | 1 | E | B | 1 | C | + | + | + |
49 | MO6-24/O | 2 | C | B | 1 | C | + | + | + |
50 | ATCC29307 | 1 | C | B | 2 | C | + | - | + |
51 | CMCP6 | 1 | C | B | 1 | C | + | - | + |
52 | WK13 | 2 | C | B | 1 | C | + | - | + |
a As shown in Fig 1.
b Selected randomly, with the exception of the reference clinical strains CMCP6, MO6-24/O, and YJ016.
c Number of strains belonging to each BOX-PCR profile.
d C, clinical source; E, environmental source.
e Determined according to the methods of Nilsson et al. [37], Han et al. [75], Roche et al. [71], Roig et al. [30], Panicker et al. [72], and Kim et al. [73].
f Not amplified.
g PCR amplicon with the expected size.